Acuta Capital Partners’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-83,350
| Closed | -$556K | – | 35 |
|
|
2025
Q1 | $556K | Sell |
83,350
-51,150
| -38% | -$341K | 0.64% | 29 |
|
|
2024
Q4 | $1.69M | Sell |
134,500
-55,500
| -29% | -$698K | 1.7% | 19 |
|
|
2024
Q3 | $3.51M | Sell |
190,000
-60,370
| -24% | -$1.12M | 2.84% | 14 |
|
|
2024
Q2 | $5.39M | Sell |
250,370
-76,417
| -23% | -$1.65M | 4.54% | 7 |
|
|
2024
Q1 | $8.8M | Sell |
326,787
-39,228
| -11% | -$1.06M | 5.72% | 5 |
|
|
2023
Q4 | $11M | Buy |
366,015
+4,015
| +1% | +$120K | 6.17% | 3 |
|
|
2023
Q3 | $7.42M | Buy |
362,000
+55,806
| +18% | +$1.14M | 4.97% | 6 |
|
|
2023
Q2 | $6.08M | Buy |
306,194
+8,194
| +3% | +$163K | 4.12% | 8 |
|
|
2023
Q1 | $5.1M | Buy |
298,000
+38,000
| +15% | +$651K | 3.76% | 10 |
|
|
2022
Q4 | $5.09M | Buy |
+260,000
| New | +$5.09M | 3.13% | 16 |
|
|
2021
Q1 | – | Sell |
-20,000
| Closed | -$1.1M | – | 55 |
|
|
2020
Q4 | $1.1M | Buy |
+20,000
| New | +$1.1M | 0.3% | 42 |
|
|
2018
Q2 | – | Sell |
-350,000
| Closed | -$6.56M | – | 53 |
|
|
2018
Q1 | $6.56M | Buy |
+350,000
| New | +$6.56M | 1.07% | 17 |
|